Skip to main content
Fig. 2 | Biomaterials Research

Fig. 2

From: Treatment of bladder cancer by geoinspired synthetic chrysotile nanocarrier-delivered circPRMT5 siRNA

Fig. 2

Formulation of SCNTs/siRNA and assessment of non-specific cytotoxicity. (A) Gel retardation results of different weight ratios of SCNTs loaded with siRNA. (B) SCNTs/siRNA cytotoxicity assays. SCNTs/siRNA at different SCNT concentrations were incubated with cells for 48 h. A CCK-8 kit was used to assess cell viability. Data are presented as mean ± SD from three independent experiments, which were performed in triplicate. **P < 0.01

Back to article page